Literature DB >> 24551630

A study on factors affecting low back pain and safety and efficacy of NSAIDs in acute low back pain in a tertiary care hospital of Western Nepal.

Srijana Bhattarai1, Himal Paudel Chhetri2, Kadir Alam3, Pabin Thapa4.   

Abstract

INTRODUCTION: Low back pain is characterized by a range of symptoms which include pain, muscle tension or stiffness, and is localized between the shoulder blades and the folds of the buttocks, with or without spreading to the legs. Non-Steroidal Anti Inflammatory Drugs (NSAIDs) are the drugs of choice which provide an analgesic effect for acute low back pain. AIM: To study the factors affecting low back pain, efficacy and safety of different non-steroidal anti-inflammatory drugs (aceclofenac, diclofenac, naproxen and nimesulide) in low back pain.
METHODOLOGY: Data collection form and numeric pain rating scale were used as study tools for studying patients' demographies and severities of pain respectively. Patients prescribed with aceclofenac 100 mg , diclofenac 100 mg, naproxen 500 mg and nimesulide 100 mg for acute low back pain at Orthopaedics Outpatients Department of Manipal Teaching Hospital, Nepal, were enrolled in this study. The decrease in pain scores was recorded on 5th and 10th days of follow-up and pain scores were calculated. Descriptive statistics and Kruskal Wallis non parametric test were used for analysis.
RESULTS: Among 150 patients, 67.3% were females (n=101). Low back pain was more prevalent (24.7%) in age-group of 59-68 years and a positive correlation was seen. Similarly, low back pain was found to be high among people involved in agriculture, heavy weight lifters and non smokers. The decrease in average pain scores was more in the patients treated with aceclofenac (4.83 ± 0.537), followed by that in those who were treated with naproxen (4.13 ± 0.067) and diclofenac (3.84 ± 0.086). The decrease in pain scores was found to be lowest among patients who were treated with nimesulide (2.11 ± 0.148). Nimesulide presented more number of side-effects than the comparative drugs.
CONCLUSION: Different factors affect low back pain, such as age, gender, personal habit, posture, occupation, weight lifting. Aceclofenac showed greater decrease in pain scores with lesser number of side-effects.

Entities:  

Keywords:  Low back pain; Non-steroidal anti-inflammatory drugs; Pain scale

Year:  2013        PMID: 24551630      PMCID: PMC3919417          DOI: 10.7860/JCDR/2013/6520.3752

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

Review 1.  Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group.

Authors:  M W van Tulder; R J Scholten; B W Koes; R A Deyo
Journal:  Spine (Phila Pa 1976)       Date:  2000-10-01       Impact factor: 3.468

Review 2.  A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain.

Authors:  Thomas J Schnitzer; Aimee Ferraro; Elke Hunsche; Sheldon X Kong
Journal:  J Pain Symptom Manage       Date:  2004-07       Impact factor: 3.612

Review 3.  Epidemiology of back disorders: prevalence, risk factors, and prognosis.

Authors:  Nisha J Manek; A J MacGregor
Journal:  Curr Opin Rheumatol       Date:  2005-03       Impact factor: 5.006

4.  The treatment of acute low back pain--bed rest, exercises, or ordinary activity?

Authors:  A Malmivaara; U Häkkinen; T Aro; M L Heinrichs; L Koskenniemi; E Kuosma; S Lappi; R Paloheimo; C Servo; V Vaaranen
Journal:  N Engl J Med       Date:  1995-02-09       Impact factor: 91.245

Review 5.  Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials.

Authors:  B W Koes; R J Scholten; J M Mens; L M Bouter
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

6.  Epidemiology of low back pain.

Authors:  L Manchikanti
Journal:  Pain Physician       Date:  2000-04       Impact factor: 4.965

7.  An evaluation of musculoskeletal disorder and socioeconomic status of farmers in West Bangal, India.

Authors:  S K Kar; P C Dhara
Journal:  Nepal Med Coll J       Date:  2007-12

8.  A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain.

Authors:  M Schattenkirchner; K A Milachowski
Journal:  Clin Rheumatol       Date:  2003-05       Impact factor: 2.980

9.  Clinical course and prognostic factors in acute low back pain: an inception cohort study in primary care practice.

Authors:  J Coste; G Delecoeuillerie; A Cohen de Lara; J M Le Parc; J B Paolaggi
Journal:  BMJ       Date:  1994-02-26

Review 10.  Aceclofenac in the management of inflammatory pain.

Authors:  Erik Legrand
Journal:  Expert Opin Pharmacother       Date:  2004-06       Impact factor: 3.889

  10 in total
  4 in total

1.  Participation in physical activity and back pain among an elderly population in South Asia.

Authors:  Ghose Bishwajit; Shangfeng Tang; Sanni Yaya; Zhanchun Feng
Journal:  J Pain Res       Date:  2017-04-15       Impact factor: 3.133

2.  Results of a feasibility randomised clinical trial on pain education for low back pain in Nepal: the Pain Education in Nepal-Low Back Pain (PEN-LBP) feasibility trial.

Authors:  Saurab Sharma; Mark P Jensen; G Lorimer Moseley; J Haxby Abbott
Journal:  BMJ Open       Date:  2019-03-27       Impact factor: 2.692

3.  A comparative study of aceclofenac versus etoricoxib in the management of acute low back pain in a tertiary care hospital.

Authors:  Hema Jagannathan; Amulya Thota; Ashok Kumar B Kumarappa; Githa Kishore
Journal:  J Drug Assess       Date:  2020-03-31

4.  Ronald Melzack Award Lecture: Putting the brain to work in cognitive behavioral therapy for chronic pain.

Authors:  Beverly E Thorn
Journal:  Pain       Date:  2020-09       Impact factor: 7.926

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.